APA (7th ed.) Citation

B, Z., X, W., H, N., W, Q., R, Z., IS, C., . . . J, S. (2023). Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19. Science immunology, 8(82), eadf0348. https://doi.org/10.1126/sciimmunol.adf0348

Chicago Style (17th ed.) Citation

B, Zhu, et al. "Inhibition of the Mitochondrial Pyruvate Carrier Simultaneously Mitigates Hyperinflammation and Hyperglycemia in COVID-19." Science Immunology 8, no. 82 (2023): eadf0348. https://doi.org/10.1126/sciimmunol.adf0348.

MLA (9th ed.) Citation

B, Zhu, et al. "Inhibition of the Mitochondrial Pyruvate Carrier Simultaneously Mitigates Hyperinflammation and Hyperglycemia in COVID-19." Science Immunology, vol. 8, no. 82, 2023, p. eadf0348, https://doi.org/10.1126/sciimmunol.adf0348.